Smart Biopsy Device Could Diagnose Breast Cancer Using Miniature Radiofrequency Sensors
Normally, when a physician notices a suspicious mass or lesion on a mammogram, he or she will request an ultrasound to explore it further. Based on those results, a biopsy may be performed to determine whether the mass is cancerous. “Unfortunately, right now, in some cases, physicians either overdiagnose or underdiagnose based on that biopsy, because with ultrasound they can only see so much,” said Lori Chmura, CEO of Dune Medical Devices. “The doctor is essentially going in blindly, trying to see what looks like the most suspicious area, and they’re t...
Source: MDDI - March 12, 2019 Category: Medical Devices Authors: Susan Shepard Tags: Business Source Type: news

New machine learning method could spare some women from unnecessary breast surgery
(Dartmouth-Hitchcock Medical Center) Dartmouth researchers have developed and evaluated a machine learning approach of using patient core needle biopsy data to identify the risk that atypical ductal hyperplasia (ADH) breast lesions may upgrade to cancer. This knowledge can potentially help clinicians and low-risk patients decide whether active surveillance and hormonal therapy is a reasonable management approach. Using the method could spare patients with benign lesions from invasive surgeries while maintaining high sensitivity for predicting malignant lesions. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 12, 2019 Category: International Medicine & Public Health Source Type: news

Cook affirms safety record of Zilver PTX stents
In response to a recent meta-analysis that linked paclitaxel-coated devices...Read more on AuntMinnie.comRelated Reading: IZI buys Cook biopsy, breast localization needle assets Cook recalls catheters with Beacon tip Cook recalls angiography catheters Cook begins inferior vena cava filter studies Cook debuts new embolization coil (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 23, 2019 Category: Radiology Source Type: news

IZI buys Cook biopsy, breast localization needle assets
Interventional radiology technology provider IZI Medical Products has purchased...Read more on AuntMinnie.comRelated Reading: Cook recalls catheters with Beacon tip Cook recalls angiography catheters Cook begins inferior vena cava filter studies Cook debuts new embolization coil Landauer buys IZI Medical Products (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 8, 2019 Category: Radiology Source Type: news

IZI Medical picks up Cook Medical ’ s Quick-Core biopsy and breast localization needle assets
IZI Medical Products extended its M&A spree today with the acquisition of a set of biopsy and breast localization needles from Cook Medical for an undisclosed amount. Last September YY-based IZI picked up Benvenue Medical’s vertebral augmentation portfolio, also for an undisclosed amount; in May 2017, the company paid an unspecified price for Cook’s vertebroplasty devices, including the Duro-Ject Osteo-Site, Osteo-Force and Vertefix brands. The latest deal with Cook includes the Quick-Core biopsy needle, MReye breast localization coil and the Kopans and X-Reidy lesion localization needles, IZI said. The...
Source: Mass Device - January 8, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Featured Mergers & Acquisitions Wall Street Beat Women's Health Cook Medical IZI Mecial Products LLC Source Type: news

US-CNB Superior for Axillary Staging in Breast Cancer US-CNB Superior for Axillary Staging in Breast Cancer
Dr Lowenfels reviews a study that compares diagnostic accuracy of ultrasound-guided fine-needle aspiration and ultrasound-guided core-needle biopsy for axillary staging in breast cancer.Medscape General Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 9, 2018 Category: Consumer Health News Tags: General Surgery Viewpoint Source Type: news

Robot arm assists with PET/CT-guided needle biopsies
By combining a robotic arm-assisted needle navigation system with PET/CT, researchers...Read more on AuntMinnie.comRelated Reading: FDG-PET/CT fails for peripheral T-cell lymphoma outcomes FDG-PET/CT helps stage men with breast cancer, too PET/CT key to NIH's tuberculosis research plan PET/CT makes case for directing cervical cancer treatment Can deep learning monitor lesions on F-18 NaF PET/CT? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 6, 2018 Category: Radiology Source Type: news

Health Tip: What to Expect From a Breast Biopsy
-- A breast biopsy involves removing a sample of breast tissue or fluid to test for the presence of cancerous cells. The U.S. National Library of Medicine says here ' s what you can expect from a non-surgical needle biopsy: You will lay on your side... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 24, 2018 Category: General Medicine Source Type: news

AirXpanders Is Pumped for Anticipated Growth After Recent Financing
The company responsible for the first major change in breast tissue expansion in almost 40 years is getting strong support from investors. San Jose, CA-based AirXpanders recently closed a rights offering in Australia to raise roughly A$15.7 million, along with a U.S. placement to raise about $3.4 million (A$4.6 million), equivalent to a total of about $15 million before transaction costs. Vivo Ventures invested $3.3 million of the U.S. placement and the company's board chairman invested $500,000. "We are confident of the outlook for the company and the successful closing of our A$20.3 million raising places us ...
Source: MDDI - September 13, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Implants Source Type: news

Nonradioactive Breast Cancer Marking Platform Gains Second Nod from FDA
Most breast cancer patients have some type of surgery to take out their tumors. But that is not sufficient to ensure that all cancer cells are found and removed. “Cancer cells primarily use the lymphatic system to spread throughout the body and are most like to be found in the first draining lymph node, as the node filters out these cells,” said Mathew Stephens, commercial director, Endomag, in an interview with MD+DI. “These ‘sentinel’ nodes are the most likely place to find cancer, and so the surgeon will want to be able...
Source: MDDI - September 4, 2018 Category: Medical Devices Authors: Susan Shepard Tags: Business Source Type: news

7 medtech stories we missed this week: June 22, 2018
[Image from unsplash.com]From Accuray’s India approval to Masimo and PositiveID launching a Bluetooth-enabled thermometer, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. India approves Accuray’s Radixact X9 radiation therapy device Accuray announced in a June 21 press release that it has received an Atomic Energy Regulatory Board Type Approval in India for its Radixact X9 System. The approval allows the company to sell the TomoTherapy platform while allowing hospitals throughout India to import the system. The Radixact and TomoTherapy Systems are radiation therap...
Source: Mass Device - June 22, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Cardiovascular Diagnostics Endoscopic / Arthroscopic Food & Drug Administration (FDA) Hospital Care Imaging Patient Monitoring Regulatory/Compliance Ultrasound Accuray Inc. Arcuro Medical BTG Masimo MedTech NuSight P Source Type: news

4 Trends Advancing Medtech
For the past 20 years, the Medical Design Excellence Awards have celebrated medical products that improve the quality and accessibility of healthcare. Our finalists this year carry on this tradition, while also keeping in step with today’s high-tech digital and consumer trends. With the help of our esteemed jurors, we have identified four key trends in this year’s group of finalists: risk reduction; faster, more-efficient healthcare delivery; the influence of the Internet of Things; and the consumerization of healthcare. We’ve been tracking a few of these trends in past awards programs, so they’re not necessarily n...
Source: MDDI - April 27, 2018 Category: Medical Devices Authors: Daphne Allen Tags: MD & M East (New York) Design Source Type: news

Abortions in the U.S. Are Safe and Effective, a New Report Says
The majority of legal abortions performed in the U.S. are safe, free of complications and devoid of long-term health effects, according to a comprehensive new report. A committee assembled by the National Academies of Sciences, Engineering, and Medicine analyzed available data on abortion safety, quality and care. The resulting report, published Friday, says the four major abortion methods used in the U.S. — medication, aspiration, induction and dilation and evacuation (D&E) — are all safe and effective, and that complications are rare. The vast majority of U.S. abortions — 90% — are also perfor...
Source: TIME: Health - March 16, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime onetime Reproductive Health Source Type: news

Artificial intelligence could prevent breast cancer false positives: Here ’s how
[Image from maf04 on Flickr]Artificial intelligence could improve detection and diagnosis of breast cancer and eliminate false positives, according to new research out of the Massachusetts Institute of Technology’s Computer Science and Artificial Intelligence Laboratory (CSAIL). A team of researchers from MIT’s CSAIL, Massachusetts General Hospital and Harvard Medical School developed an AI system with machine learning that can predict if high-risk lesions on needle biopsies found during a mammogram will turn out to be cancerous after surgery. High-risk lesions that appear on mammograms and have abnormal cells when tes...
Source: Mass Device - October 19, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Oncology Research & Development Women's Health artificial intelligence Breast Cancer Harvard Medical School Massachusetts General Hospital Massachusetts Institute of Technology MedTech Source Type: news

Diagnostic Performance of USFNA of Nonpalpable Breast Lesions Diagnostic Performance of USFNA of Nonpalpable Breast Lesions
How well does ultrasound-guided fine-needle aspiration perform as a diagnostic procedure in nonpalpable breast lesions? How does it compare to other biopsy methods?American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 6, 2017 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news